Treatment of Periorbital Pruritus
The first-line treatment for periorbital pruritus should be topical calcineurin inhibitors such as tacrolimus 0.03-0.1% or pimecrolimus 1% cream applied twice daily, as they are safe and effective for periorbital dermatitis and associated pruritus. 1
Evaluation and Initial Management
- First determine if periorbital pruritus is related to an underlying dermatosis (like atopic dermatitis, contact dermatitis) or a systemic condition 2
- Common causes of periorbital dermatitis include allergic contact dermatitis (32-44%), atopic eczema (14-25%), airborne contact dermatitis (2-10%), and irritant contact dermatitis (8-9%) 1
- Risk factors include female gender, atopic skin diathesis, and age over 40 years 1
- Consider medication-induced periorbital dermatitis in patients taking new medications (e.g., apixaban has been reported to cause periorbital dermatitis) 3
Treatment Algorithm
First-line treatments:
Second-line treatments:
- Non-sedating antihistamines (fexofenadine or loratadine) for pruritus relief 2
- Emollients to maintain skin hydration and repair barrier function 2, 6
- Topical menthol preparations for temporary relief of pruritus 2
For refractory cases:
- Consider short-term, low-potency topical corticosteroids (use cautiously in periorbital area due to risk of glaucoma, cataracts, and skin atrophy) 6, 7
- Investigate for underlying systemic causes if pruritus persists despite appropriate topical therapy 8, 2
Management of Underlying Systemic Causes
If hematological disorders are suspected:
- Order full blood count, blood film, lactate dehydrogenase and ESR 8
- For polycythemia vera-associated pruritus:
If lymphoma is suspected:
- Consider cimetidine, gabapentin, carbamazepine, mirtazapine or phototherapy 8
- For incurable lymphoma, oral corticosteroids may provide relief 8
For solid tumor-associated pruritus:
For hepatic pruritus:
- First-line: rifampicin 8, 2
- Second-line: cholestyramine 8, 2
- Avoid gabapentin in hepatic pruritus 8, 2
For uremic pruritus:
- Optimize dialysis parameters, normalize calcium-phosphate balance 8, 2
- BB-UVB phototherapy is effective 8, 2
Important Considerations and Pitfalls
- Avoid long-term use of sedative antihistamines except in palliative care settings due to potential dementia risk 8, 2
- For periorbital application, ensure medications do not enter the eyes; if they do, rinse with cold water 5
- Limit sun exposure during treatment with calcineurin inhibitors and avoid UV light therapy 5
- If symptoms do not improve after 6 weeks of treatment, reevaluate diagnosis as other skin diseases can mimic eczema 5
- Discontinue suspected causative medications if possible and consider alternatives 3